BillionToOne Inc
BLLN
Company Profile
Business description
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
Contact
1035 O’Brien Drive
Menlo ParkCA94025
USAT: +1 650 460-2551
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
stocks
2 ASX shares that benefit from sticky inflation
Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks
Undervalued ASX retailer benefiting from rebound in spending
Uplift in sales momentum continues.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,874.20 | 25.80 | 0.29% |
| CAC 40 | 8,095.58 | 10.58 | -0.13% |
| DAX 40 | 24,074.25 | 2.62 | -0.01% |
| Dow JONES (US) | 48,262.16 | 147.90 | 0.31% |
| FTSE 100 | 9,838.60 | 153.81 | 1.59% |
| HKSE | 25,468.78 | 233.37 | 0.92% |
| NASDAQ | 23,079.47 | 32.00 | -0.14% |
| Nikkei 225 | 49,512.28 | 128.99 | 0.26% |
| NZX 50 Index | 13,295.91 | 129.04 | -0.96% |
| S&P 500 | 6,798.20 | 2.06 | -0.03% |
| S&P/ASX 200 | 8,585.20 | 21.60 | 0.25% |
| SSE Composite Index | 3,870.28 | 45.47 | 1.19% |